
|Articles|September 1, 2002
Fluconazole Tx for cutaneous leishmaniasis
Riyadh, Saudi Arabia - For treatment of cutaneous leishmaniasis caused by Leishmania major, a six-week course of oral fluconazole is effective and avoids the potentially severe side effects of standard parenteral therapy, according to Abdulrahman A. Alrajhi, M.D., M.P.H.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
Dermatology Conferences and Meetings Calendar: December 2025
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5


















